Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients
NCT ID: NCT01309529
Last Updated: 2011-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
45 participants
OBSERVATIONAL
2011-03-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Patient Removal of Urinary Catheters After Urogynecologic Surgery
NCT06344884
Post-Surgical Based Efforts to Reduce Preventable Readmissions and Optimize Length of Stay
NCT04881708
Critical Incidents Related to Anesthesia and Intensive Care: A Study in a Tertiary Hospital
NCT02681159
Urinary Infection and Colonization in Bone Procedures
NCT06896643
Cognitive Recovery Between Intubated and Non-intubated Thoracic Surgery
NCT04057586
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sampling will include all patients that meet the eligibility criteria from March 01, 2011 until August 01, 2011 with a goal of forty-five patients.
Data Collection Protocol
1. The patient will be interviewed and given information regarding participation in the study by Principal Investigator and/or research team prior to surgery. Informed Consent Forms will be collected by Principal Investigator and/or research team. Principal Investigator and/or research team will collect all data on Data Collection Sheet.
2. Thoracic epidural will be placed by the anesthesiologist in pre-op per standard protocol.
* Location of epidural will be documented by Principal Investigator and/or research team on Data Collection Sheet. (See Appendix 1)
3. Prior to surgery, if indicated, an indwelling urinary bladder catheter will be placed per pre-operative protocol.
4. Post-operative documentation of time, type and settings for epidural infusion will be documented on Data Collection Sheet.
5. Post-op eligible patients admitted to cardiothoracic step-down unit will be placed on the following protocol:
* Thoracic Epidural will be managed by the anesthesia group.
* Any change in prescription or dosing will be documented on the Data Collection Sheet.
* If urinary catheter present, will be discontinued at midnight day of surgery, Day Zero; the time of discontinuation will be noted on the Data Collection Sheet.
* If micturition occurs, amount and time will be documented on Data Collection Sheet.
* If no spontaneous void by 0800 post-operative day (POD) 1, bladder scanning will be initiated.
* If ≥ 400 cc per bladder scanner, the thoracic surgeon, surgeon's nurse or the Principal Investigator will not notified.
* Any ordered interventions, the response and re- evaluation will be noted on Data Collection Sheet.
* Urinary retention will be defined as \> 400 cc and recatheterization (either intermittent or indwelling) will occur.
6. Data will only be collected during current surgery hospitalization.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
thoracic surg, epidural, urine retention
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of urologic procedure
* Known benign prostatic hyperplasia
* Admission to intensive care units
* History of urinary retention
* Foreign speaking patient
* Pregnant women and those less than 18 years old
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Memorial Hospital-Thoracic Program
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurel Rhyne, ACNP-BC
Role: PRINCIPAL_INVESTIGATOR
Memorial Hospital-Thoracic Program
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Hospital
Chattanooga, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB11.03.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.